1. Academic Validation
  2. Identification of a novel dihydrodaidzein racemase essential for biosynthesis of equol from daidzein in Lactococcus sp. strain 20-92

Identification of a novel dihydrodaidzein racemase essential for biosynthesis of equol from daidzein in Lactococcus sp. strain 20-92

  • Appl Environ Microbiol. 2012 Jul;78(14):4902-7. doi: 10.1128/AEM.00410-12.
Yoshikazu Shimada 1 Masayuki Takahashi Norihiro Miyazawa Yasuhiro Abiru Shigeto Uchiyama Haretsugu Hishigaki
Affiliations

Affiliation

  • 1 Institute of Biomedical Innovation, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan. [email protected]
Abstract

Equol is metabolized from daidzein, a soy isoflavone, by the gut microflora. In this study, we identified a novel dihydrodaidzein racemase (L-DDRC) that is involved in equol biosynthesis in a lactic acid bacterium, Lactococcus sp. strain 20-92, and confirmed that histidine-tagged recombinant L-DDRC (L-DDRC-His) was able to convert both the (R)- and (S)-enantiomers of dihydrodaidzein to the racemate. Moreover, we showed that recombinant L-DDRC-His was essential for in vitro equol production from daidzein by a recombinant Enzyme mixture and that efficient in vitro equol production from daidzein was possible using at least four enzymes, including L-DDRC. We also proposed a model of the metabolic pathway from daidzein to equol in Lactococcus strain 20-92.

Figures
Products